Records containing: Ovarian Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-08-14Study of Serum Measured Folate Receptor and Its Induction as a Biomarker in the Diagnosis and Surveillance of Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2018-04-05A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2017-10-06Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Low Burden Adenocarcinoma of the Ovary
-
CLINICAL_TRIALS study record update · 2017-07-02Microarray Analysis for Human Genetic Disease
-
CLINICAL_TRIALS study record update · 2017-04-05Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-10Phase 1b Exploratory Study of [18F]Fluciclatide-PET as a Marker of Angiogenic Response to Combination Therapy With the Pan-VEGF Inhibitor, Pazopanib, and Weekly Paclitaxel in Platinum Resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2016-12-30Intraoperative Fluid Balance During Cytoreductive Surgery for Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-06-18Prediction of Ovarian Malignancy, in the Presence of Sonographic Pelvic Mass Using Patient History, Sonographic Parameters and Serum Markers
-
CLINICAL_TRIALS study record update · 2015-03-26A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2015-01-26A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-02-02A Phase I, Open-Label, Dose Escalating, Multiple Dose Study to Determine the Safety, Tolerability, Maximum Tolerated Dose and Pharmacokinetics of Oral TAK-165 Administered Once Daily to Subjects With Tumors Known to Express HER2.
-
CLINICAL_TRIALS study record update · 2011-10-12A Phase II Non-randomized Study of DOXIL Consolidation Treatment for Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneal Carcinoma.
-
CLINICAL_TRIALS study record update · 2008-09-22CT-2103/Carboplatin for Patients With Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study